The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Advancement Program, 2016Upregulation of Autophagy by Tet3-mediated 5-methylcytosine oxidation – Relevance to Parkinson's Disease
Study Rationale:
An abnormally folded version of the protein alpha-synuclein forms characteristic clumps (Lewy bodies) in nerve cells in Parkinson's disease (PD). One possible reason for this is an... -
Target Advancement Program, 2016Role of PINK1 and Parkin in Innate Immunity: Crosstalk between Mitochondrial Dysfunction and NLRP3 Inflammasome Signaling
Study Rationale:
Mitochondrial dysfunction and neuroinflammation play major roles in Parkinson's disease (PD). Overactivation of the inflammasome (innate immune system receptor) signaling complex NLRP3... -
Target Advancement Program, 2016Evaluation of PARIS (ZNF746) as a Target of Alpha-synuclein Toxicity in Parkinson's Disease and Alpha-synucleinopathies
Study Rationale:
We have recently identified Parkin-Interacting Substrate (PARIS), a Kruppel associated box (KRAB) and zinc finger protein, as a substrate of the parkin, E3 ubiquitin ligase. PARIS... -
Target Advancement Program, 2016Targeting Novel Transcriptional Pathways to Reduce Alpha-synuclein Expression
Study Rationale:
Many scientific studies have shown that one of the major causes of Parkinson's disease (PD) is the accumulation of a protein named alpha-synuclein in a certain type of neurons. When... -
Target Advancement Program, 2016Investigating the Effect of Parkin on Alpha-synuclein Propagation
Study Rationale:
Parkinson's disease (PD) has been demonstrated to start within the olfactory bulb (brain region that processes smell) and brain stem (brain region that controls involuntary functions)... -
Target Advancement Program, 2016Structural Insights into Activated Intermediates of Parkin
Study Rationale:
Failure in the quality control of mitochondria (power houses of the cell) in neurons may contribute to Parkinson's disease (PD). Parkin is an enzyme that tags proteins from damaged...
![Two female doctors talking in the lab.](/sites/default/files/styles/ad_callout_single/public/images/ad/apply-for-grant-404-Large-Image-Callout-A-1.jpg?h=2a1ad497&itok=-_5jZ5iX)
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.